Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds

Abstract New 9-(alkyl/aryl)-4-fluoro-6-oxo[1,2,5]thiadiazolo[3,4-h]quinoline-5-carboxylic acids and their esters were designed and synthesized. A detailed discussion of the reactions utilized in the preparation of the intermediate and target compounds is reported. All the newly synthesized compounds were fully characterized using all the physico-chemical means needed. All the intermediates and the final esters and acids were tested against bacterial and fungal strains. The acids 25a and 25c proved to be very active against Gram positive and Gram negative bacteria with MIC 0.15–3 µg/mL. The structure–activity relationship of antibacterial thiadiazoloquinolones shows that compounds 25a and 25c are twice less potent than the corresponding cyclopropyl derivative 16. Therefore, the cyclopropyl moiety on N-9 seems to be the most suitable substituent.

[1]  Hisashi Takahashi,et al.  Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens. , 2013, Journal of medicinal chemistry.

[2]  M. K. Kathiravan,et al.  Topoisomerase as target for antibacterial and anticancer drug discovery , 2013, Journal of enzyme inhibition and medicinal chemistry.

[3]  Rosaleen J. Anderson,et al.  Quinolone Antibacterial Agents , 2012 .

[4]  Jalal A. Zahra,et al.  Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents. , 2011, Bioorganic & medicinal chemistry.

[5]  Jalal A. Zahra,et al.  Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents. , 2010, Bioorganic & medicinal chemistry.

[6]  Jalal A. Zahra,et al.  Synthesis and antibacterial activity of 9-cyclopropyl-4-fluoro-6-oxo- 6,9-dihydro-(1,2,5)thiadiazolo(3,4-h)quinoline-7-carboxylic acid and its ethyl ester , 2009 .

[7]  L. Kamen,et al.  A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. , 2008, Current medical research and opinion.

[8]  A. Wagman 7.19 – Quinolone Antibacterial Agents , 2007 .

[9]  A. Shafiee,et al.  Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria. , 2006, Mini reviews in medicinal chemistry.

[10]  D. J. Triggle,et al.  Comprehensive medicinal chemistry II , 2006 .

[11]  L. Mitscher Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. , 2005, Chemical reviews.

[12]  A. Bryskier Antimicrobial agents: antibacterials and antifungals. , 2005 .

[13]  S. Paisley,et al.  Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review , 2002, Multiple sclerosis.

[14]  L. Mitscher,et al.  The 2‐pyridone antibacterial agents: bacterial topoisomerase inhibitors , 2000, Medicinal research reviews.

[15]  T. Gootz,et al.  Chemistry and Mechanism of Action of the Quinolone Antibacterials , 2000 .

[16]  H. Lamb,et al.  Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. , 2000, Drugs.

[17]  A. Krebs,et al.  The Synthesis and Biological Properties of 6-Fluoroquinolonecarboxylic Acids , 1997 .

[18]  L. Heifets,et al.  Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages , 1994, Antimicrobial Agents and Chemotherapy.

[19]  M. Tashiro,et al.  Sulfur Nitride in Organic Chemistry. Part 19. Selective Formation of Benzo- and Benzobis[1,2,5]thiadiazole Skeleton in the Reaction of Tetrasulfur Tetranitride with Naphthalenols and Related Compounds , 1991 .

[20]  Hutchinson Dr Modified release tizanidine: a review , 1989 .

[21]  P. Fernandes,et al.  Structure-activity relationships of the fluoroquinolones , 1989, Antimicrobial Agents and Chemotherapy.

[22]  K. Grohe,et al.  Cycloaracylierung von Enaminen, II. Synthese von 1-Amino-4-chinolon-3-carbonsäuren , 1987 .

[23]  P. Fernandes,et al.  Synthesis and structure-activity relationship of 1-aryl-6,8-difluoroquinolone antibacterial agents. , 1987, Journal of medicinal chemistry.

[24]  P. Fernandes,et al.  Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents. , 1985, Journal of medicinal chemistry.

[25]  G. Ridgway,et al.  Comparative in vitro studies with 4-quinolone antimicrobials. , 1985, Drugs under experimental and clinical research.

[26]  K. Sharma,et al.  Condensed Heterocycles; Xl. Synthesis of 1,2,5-Thia(selena)diazolo[3,4-b]quinolines and 1,2,5-Thia(selena)diazolo[3,4-h]quinolines , 1981 .

[27]  R. Singh,et al.  CONDENSED HETEROCYCLES; XI. SYNTHESIS OF 1,2,5-THIA(SELENA)DIAZOLO(3,4-B)QUINOLINES AND 1,2,5-THIA(SELENA)DIAZOLO(3,4-H)QUINOLINES , 1981 .

[28]  H. Koga,et al.  Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. , 1980, Journal of medicinal chemistry.

[29]  D. Klamann,et al.  Über Pseudonitrosite, Nitroxime und Furoxane , 1965 .

[30]  V. G. Pesin,et al.  Behavior of 4- and 5-aminobenz-2,1,3-thiadiazoles under Herz and Skraup reaction conditions , 1965 .